<DOC>
	<DOC>NCT01736592</DOC>
	<brief_summary>The purpose of the study is to examine the long term safety of an experimental gene transfer agent, SAR422459, designed to treat Stargardt Macular Degeneration.</brief_summary>
	<brief_title>A Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Must have received a subretinal injection of SAR422459. Must have completed protocol TDU13583 to Week 48 or undergone an early discontinuation visit. Did not receive SAR422459 as part of the TDU13583 protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>